|

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

NOT_RECRUITINGSponsored by Carol Davila University of Medicine and Pharmacy
No longer actively recruiting
SponsorCarol Davila University of Medicine and Pharmacy
Started2024-08-01
Est. completion2024-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06224023

Summary

The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* patient with ascites and chronic liver failure
* no contraindications and technical possibility to perform diagnostic paracentesis
* age above 18 years old
* informed consent

Exclusion Criteria:

* contraindications to paracentesis or technical impossibility to perform paracentesis
* absence of informed consent

Conditions4

Ascites HepaticCirrhosis, LiverLiver DiseaseLiver Failure

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.